Lorien Shakib

ORCID: 0000-0003-2502-2049
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Immune cells in cancer
  • Cytokine Signaling Pathways and Interactions
  • Cancer Immunotherapy and Biomarkers
  • CRISPR and Genetic Engineering
  • Acute Myeloid Leukemia Research
  • Cytomegalovirus and herpesvirus research
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Pluripotent Stem Cells Research
  • T-cell and B-cell Immunology
  • Renal and related cancers
  • RNA modifications and cancer
  • RNA Interference and Gene Delivery
  • Chronic Kidney Disease and Diabetes
  • Circadian rhythm and melatonin
  • Chemokine receptors and signaling
  • Renal Diseases and Glomerulopathies
  • Orthopedic Infections and Treatments
  • Orthopaedic implants and arthroplasty
  • Spaceflight effects on biology
  • MicroRNA in disease regulation
  • Advanced biosensing and bioanalysis techniques
  • Rheumatoid Arthritis Research and Therapies
  • Genetics, Aging, and Longevity in Model Organisms

Hospital for Special Surgery
2023-2024

Cornell University
2020-2023

Princess Margaret Cancer Centre
2018-2022

University Health Network
2018-2022

Abstract Background Immunosuppressive and anti-cytokine treatment may have a protective effect for patients with COVID-19. Understanding the immune cell states shared between COVID-19 other inflammatory diseases established therapies help nominate immunomodulatory therapies. Methods To identify cellular phenotypes that be across tissues affected by disparate diseases, we developed meta-analysis integration pipeline models removes effects of technology, tissue origin, donor confound cell-type...

10.1186/s13073-021-00881-3 article EN cc-by Genome Medicine 2021-04-20

Immune checkpoint inhibitor (ICI) therapies used to treat cancer, such as anti–PD-1 antibodies, can induce autoimmune conditions in some individuals. The T cell mechanisms mediating iatrogenic autoimmunity and their overlap with spontaneous diseases remain unclear. Here, we compared cells from the joints of 20 patients an inflammatory arthritis induced by ICI therapy (ICI-arthritis) two archetypal arthritides, rheumatoid (RA) psoriatic (PsA). Single-cell transcriptomic antigen receptor...

10.1126/sciimmunol.add1591 article EN Science Immunology 2023-07-28

Abstract In the human hematopoietic system, rare self-renewing multipotent long-term stem cells (LT-HSCs) are responsible for lifelong production of mature blood and rational target clinical regenerative therapies. However, heterogeneity in cell compartment variable outcomes CRISPR/Cas9 editing make functional interrogation LT-HSCs challenging. Here, we report high efficiency LT-HSC at single-cell resolution using electroporation modified synthetic gRNAs Cas9 protein. Targeted short isoform...

10.1038/s41467-019-12726-0 article EN cc-by Nature Communications 2019-10-18

Immunosuppressive and anti-cytokine treatment may have a protective effect for patients with COVID-19. Understanding the immune cell states shared between COVID-19 other inflammatory diseases established therapies help nominate immunomodulatory therapies. Using an integrative strategy, we built reference by meta-analyzing > 300,000 cells from 5 including rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), lupus, interstitial lung disease. Our cross-disease analysis...

10.1101/2020.08.05.238360 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-08-05
Philip M. Carlucci Jessica Li Andrea Fava Kristina Deonaraine David Wofsy and 95 more Judith A. James Chaim Putterman Betty Diamond Anne Davidson Derek M. Fine Jose M. Monroy‐Trujillo Mohamed G. Atta Wade DeJager Joel M. Guthridge Kristin Haag Deepak A. Rao Michael B. Brenner James A. Lederer William Apruzzese H. Michael Belmont Peter Izmirly Devyn Zaminski Ming Wu Sean Connery Fernanda Payan‐Schober Richard Furie Maria Dall’Era Kerry Cho Diane L. Kamen Kenneth Kalunian Jennifer H. Anolik Jennifer L. Barnas Mariko Ishimori Michael H. Weisman J. Le Goff Patrick Dunn Soumya Raychaudhuri Fan Zhang Ilya Korsunsky Aparna Nathan Joseph Mears Kazuyoshi Ishigaki Qian Xiao Nghia Millard Kathryn Weinand Saori Sakaue Paul J. Utz Rong Mao Bill Robinson Holden T. Maecker Susan Macwana S. Louis Bridges Vivian P. Bykerk Laura T. Donlin Susan M. Goodman Edward F. DiCarlo Melanie Smith Amit Lakhanpal Heather L. Sherman Anvita Singaraju Lorien Shakib Christopher T. Ritchlin Brendan F. Boyce Darren Tabechian Andrew McDavid Javier Rangel‐Moreno Nida Meednu Jen Albrecht Kevin Wei A. Helena Jonsson Daimon P. Simmons Gregory Keras Joshua Keegan Gerald F. Watts Yuhong Li Zhu Adam Chicoine Zhihan Jian Li Ellen M. Gravallese Kaitlyn Howard Mandy J. McGeachy Gary S. Firestein David L. Boyle Arnold Ceponis Peter K. Gregersen Diane Horowitz Harris Perlman Salina Dominguez Carla M. Cuda Arthur M Mandolin Anjali Thakrar Joan M. Bathon Laura Hughes V. Michael Holers Jennifer Seifert Kevin D. Deane Larry W. Moreland Andrew Filer Karim Raza Ilfita Sahbudin Costantino Pitzalis

Delayed detection of LN associates with worse outcomes. There are conflicting recommendations regarding a threshold level proteinuria at which biopsy will likely yield actionable management. This study addressed the association urine protein:creatinine ratios (UPCR) clinical characteristics and investigated incidence proliferative membranous histology in patients UPCR between 0.5 1.A total 275 SLE (113 first biopsy, 162 repeat) were enrolled multicentre multi-ethnic/racial Accelerating...

10.1093/rheumatology/keac067 article EN Lara D. Veeken 2022-01-27

Abstract Immune checkpoint inhibitor (ICI) therapies that promote T cell activation have improved outcomes for advanced malignancies yet also elicit harmful autoimmune reactions. The mechanisms mediating these iatrogenic events remain unclear. Here we assayed cells from joints of patients affected by ICI-induced inflammatory arthritis (ICI-arthritis), which can present clinically indistinguishable rheumatoid (RA). Compared to the arthritides RA and psoriatic (PsA), ICI-arthritis contained an...

10.1101/2021.10.19.464961 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-10-20

Abstract The I4 mission, the first all-civilian orbital flight investigated physiological effects of short duration spaceflight through a multi-omic approach. We analyzed telomere length, clonal hematopoiesis indeterminate potential (CHIP), whole genome stability, cell-free DNA (cfDNA) cell lysis, and immune gene expression. Our results revealed length dynamics similar to those observed in NASA Twins Study astronauts spending 6 months on ISS, with lengthening space shortening upon return...

10.21203/rs.3.rs-2928049/v1 preprint EN cc-by Research Square (Research Square) 2023-05-30

Objective Diagnosis of periprosthetic joint infection (PJI) in patients with inflammatory arthritis (IA) is challenging, as features IA flares can mimic infection. We aimed to cross-sectionally determine if the optimal tests diagnose PJI osteoarthritis were present flares. Methods enrolled from October 2020 July 2022 3 groups: ( a ) PJI—total arthroplasty undergoing revision for infection, b Flare—IA flaring native joint, and c Aseptic—total aseptic revision. compared blood synovial fluid...

10.1097/rhu.0000000000002157 article EN JCR Journal of Clinical Rheumatology 2024-10-30

Abstract In the human hematopoietic system, rare self-renewing multi-potent long-term stem cells (LT-HSCs) are responsible for lifelong production of mature blood and rational target clinical regenerative therapies. However, heterogeneity in cell compartment variable outcomes CRISPR/Cas9 editing make functional interrogation LT-HSCs challenging. Here, we report high efficiency LT-HSC at single resolution using electroporation modified synthetic gRNAs Cas9 protein. Targeted short isoform...

10.1101/609040 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2019-04-15
Coming Soon ...